contact us Get discount
HGH and Osteoporosis – Improve Your Bones Health

HGH and Osteoporosis – Improve Your Bones Health

December 19, 2018

HGH and Osteoporosis

Osteoporosis is a potentially debilitating medical condition that occurs when the bones become weak and brittle. When that happens, a person is more susceptible to fractures – even from something as minor as a sneeze or a cough.

When examined under a microscope, healthy bone looks similar to a honeycomb. The porous spaces (holes) in the honeycomb become larger in people with osteoporosis. The bone loses its density and mass.

Osteoporosis can occur if the supply of new bone cells cannot keep up with the resorption of old bone cells. Bones are in a constant state of remodeling as new bone cells form and old bone cells die off. It takes approximately 10 years for the entire adult skeleton to be replaced. Once old cells die, it takes about 30 to 40 days for their resorption. After that, there is a period of new bone formation that occurs over 150 days. When a person has osteoporosis, the osteoblasts (new bone cells) are not able to completely refill the resorption lacuna, resulting in a net bone loss. As the process continues, the bones slowly weaken with each cycle.

Osteopenia is the predecessor to osteoporosis. In this condition, bone density decreases, but not yet to the point of osteoporosis. It is easier to take natural steps to strengthen bone at this stage then it is to create change once you are diagnosed with osteoporosis.

Trusted sourceWhat Women Need to Know About OsteoporosisNational Osteoporosis FoundationGo to sourceResearch shows that one out of every four men, and one out of every two women over 50 will likely suffer a fracture due to osteoporosis. Within one year of suffering a hip fracture, approximately 20 percent of seniors will likely die due to complications from the injury or its surgery. Fractures are also a leading cause of debilitation and long-term nursing care


Numerous health conditions and certain types of medical procedures can significantly influence the development of osteoporosis. The National Osteoporosis Foundation provides a comprehensive listing of health conditions and medications that could potentially contribute to osteoporosis. The box below features some of the most common causes separated into categories for easy viewing (This is not a complete list):

Autoimmune Disorders Lupus, Multiple Sclerosis, Rheumatoid Arthritis
Cancer Breast Cancer, Prostate Cancer
Digestive and Gastrointestinal Disorders Celiac Disease, Colitis, Crohn’s Disease
Endocrine and Hormonal Disorders Cushing’s Syndrome, Diabetes, Hormone Deficiencies, Hyperthyroidism, Irregular Periods, Premature Menopause
Hematologic/Blood Disorders Leukemia, Lymphoma, Multiple Myeloma, Sickle Cell Disease
Mental Illness Depression, Eating Disorders
Neurological/Nervous System Disorders Multiple Sclerosis, Parkinson’s Disease, Spinal Cord Injuries, Stroke
Other Conditions and Diseases Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease (COPD) including Emphysema, Female Athlete Triad (loss of menstrual periods, eating disorder, excessive exercise), HIV/AIDS, Liver Disease (Biliary Cirrhosis), Malnutrition, Organ Transplants, Poor Diet,Scoliosis
Medical Procedures Gastrectomy, Gastrointestinal Bypass Procedures, Weight Loss Surgery
Medications Antacids containing aluminum, Antiseizure – specific brands, Cancer chemotherapy drugs, Glucocorticoids (steroids) – cortisone, prednisone, Heparin
Methotrexate, Thyroid hormones – excessive use

Excessive steroid use, whether illegal or for medical reasons can lead to bone loss. Certain steroids may help with autoimmune diseases, cancer, and organ transplants. However, they can increase the risk of osteoporosis. Getting enough vitamin D and calcium is crucial while taking steroids. Proper exercise and avoiding smoking are also important, as is getting a bone density test.

Growth hormone deficiency – a condition that reduces the production of new cells – may contribute significantly to bone loss in some adults. Menopausal women are at a greater risk of osteoporosis due to multiple hormonal declines.


Unfortunately, many people do not have any symptoms of osteoporosis until they experience a fracture. When fractures occur in people over fifty, the doctor may run diagnostic tests to check for osteoporosis. The type of fracture and how it occurred can also alert the doctor to possible osteoporosis.

For example, if the fracture was not related to a fall or accident, that will increase the doctor’s suspicion of osteoporosis. A rib fracture that occurs due to coughing or sneezing is often a sign that the bones are weakening.

Other signs that can alert you to possible osteoporosis include:

  • Height shrinkage
  • Joint pains
  • Stooped posture
  • Reduced flexibility


The doctor will determine the proper treatment to help prevent or improve osteoporosis. The type of treatment prescribed depends on risk factors based on the results of a DEXA scan and age and gender. If hormone deficiency is contributing to decreased bone density, then the appropriate hormone replacement therapy can help.

If you are over 40 years of age, there has never been a more critical time than now to learn about HGH and osteoporosis. Human growth hormone plays a crucial role in protecting bone density and decreasing the risk of fractures.

Why is learning about HGH for osteoporosis to improve bone health important?

Here are some US statistics about osteoporosis and fractures that you need to know:

  • Low bone mass is considered a major public health threat for roughly 44 million men and women over age 50
  • Approximately 10 million adults already have osteoporosis
  • Half of all adults 50 and over are currently at risk for fractures
  • Osteoporosis will cause one out of every two women and one out of every four men to fracture a bone at some point
  • Women have a higher incidence of fracturing a bone than having a stroke, heart attack, and breast cancer combined
  • Male fracture risk from osteoporosis in more common than prostate cancer
  • Adults with osteoporosis can experience a fracture simply from bumping into something or sneezing
  • There are approximately 300,000 hip fractures in the US each year with the following results:
  1. One-quarter of the patients wind up in nursing homes
  2. One-half of the patients never regain their previous function
  3. Twenty-four percent die within the following year

These facts can be sobering, but you need not worry – if you are growth hormone deficient, then HGH therapy can often help.

The Connection between HGH Deficiency and Osteoporosis

HGH does more than contribute to adolescent growth. It continues to supply to crucial cells necessary to maintain bone and muscle mass throughout adult life. Bones undergo a continual process called remodeling. Old bone cells die and require new ones to take their place. Bone resorption is the process that absorbs the old bone cells to make way for the new ones.

As we start to understand HGH and osteoporosis in this process, we see that the role of human growth hormone in stimulating cellular reproduction is critical. HGH carries out many functions, one of which is the signaling of the liver to secrete insulin growth factor 1. IGF-1 helps to mediate many of the functions of HGH, including cell regeneration. Without enough of these two hormones, the body cannot meet the demand for new cells to maintain bone and muscle mass, internal organ size, collagen and elastin for the skin, hair and nail growth, blood cells, and more.

HGH not only aids the formation of new bone cells, but it also helps bone mineralization to rebuild and strengthen the bones as old cells undergo resorption. After the old bone cells have been resorbed, if there are not enough new ones to take their place, the bones will become brittle and weak. The initial outcome is osteopenia, and that is followed by osteoporosis.

Benefits of HGH for Strengthening Bones and Reducing Osteoporosis Risk

Before you start to worry that the future looks bleak with the statistics you read in the first section, know that there is hope. By utilizing HGH treatment, osteoporosis risk can decline. Human growth hormone therapy improves cellular regeneration, helping the bones and muscle to become stronger. Since the muscles shield the bones from injury, you have a two-fold benefit from HGH treatment. Healthy bone and muscle structure are crucial to protecting the structural integrity of the body.

Studies around the world are reporting the benefits of HGH for osteoporosis and bone health. In Sweden, research on both men and women shows the following:

  1. Men who received HGH therapy experienced an increase in bone mineral density (BMD) and bone mineral content (BMC) for at least one year following cessation of treatment
  2. Women who received 36 months of HGH therapy still had higher BMD seven years following the end of treatment

The good news is that it is never too late to learn about the connection between HGH and osteoporosis. Even if you already suffer from weak bones, you can still improve your bone mineral density. Doctors specializing in hormone replacement therapy are best equipped to assess, diagnose, and treat hormonal imbalances such as HGH deficiency.

For your free consultation to learn more about preventing or treating osteoporosis with HGH therapy, contact our clinic today.

  1. >EndocrineWeb
  2. Merriam-Webster Dictionary
  3. Prevention and Management of Osteoporosis (2000: Geneva, Switzerland) (2003)
  4. Nelson, H. D; Haney, E. M; Chou, R; Dana, T; Fu, R; Bougatsos, C (2010). “Screening for Osteoporosis: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation Agency for Healthcare Research and Quality
  5. The International Society for Clinical Densitometry
  6. “Exercise, Nutrition, Hormones, and Bone Tissue”.Anatomy Physiology. Openstax CNX. 2013. ISBN 978-1-938168-13-0.
  7. Sinnesael M, Claessens F, Boonen S, Vanderschueren D (2013). “Novel insights in the regulation and mechanism of androgen action on bone”. Current Opinion in Endocrinology, Diabetes, and Obesity. 20 (3): 240–44
  8. Mirza F, Canalis E (Sep 2015). “Management of endocrine disease: Secondary osteoporosis: pathophysiology and management”. Eur J Endocrinol 73 (3):R131–51
  9. Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD (2007). “Low bone mineral density and fracture burden in postmenopausal women”. CMAJ. 177 (6): 575–80.

Leave a Reply

Your email address will not be published. Required fields are marked *